Kellogg Robert G, Munoz Lorenzo F
Department of Neurosurgery, Rush University Medical Center, Chicago, IL, USA.
Surg Neurol Int. 2013 May 17;4:66. doi: 10.4103/2152-7806.112189. Print 2013.
The surgical management of cerebral metastases to the eloquent cortex is a controversial topic. Precentral gyrus lesions are often treated with whole brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS) because of the concern for causing new or worsened postoperative neurological deficits. However, there is evidence in the literature that radiation therapy carries significant risk of complication. We present a series of patients who were symptomatic from a precentral gyrus metastasis and underwent surgical excision.
During a 2-year period from 2010 to 2012, 17 consecutive patients harboring a cerebral metastasis within the precentral gyrus underwent microsurgical resection. All patients were discussed at a multi-disciplinary tumor board. The prerequisite for neurosurgical treatment was stable systemic disease and life expectancy greater than 6 months as determined by the patient's oncologist. Patients also were required to harbor a symptomatic lesion within the motor cortex, defined as the precentral gyrus.
We present the 3-month neurological outcome for this group of patients. Surgery was uneventful and without any severe perioperative complications in all 17 patients. At 3 month follow up, symptoms had improved or been stabilized in 94.1% of patients and were worsened in 5.9%.
Our results have shown that surgery for cerebral metastases in the precentral gyrus can be done safely and improve or stabilize the neurological function of most patients. Microsurgical resection of precentral gyrus metastases should be a treatment option for patients with single or multiple lesions who present a focal neurologic deficit. This can be performed safely and without intraoperative cortical mapping.
向功能区皮质转移的脑转移瘤的外科治疗是一个有争议的话题。由于担心术后出现新的或加重的神经功能缺损,中央前回病变常采用全脑放射治疗(WBRT)或立体定向放射外科治疗(SRS)。然而,文献中有证据表明放射治疗有显著的并发症风险。我们报告了一系列因中央前回转移瘤出现症状并接受手术切除的患者。
在2010年至2012年的2年期间,17例连续的中央前回脑转移瘤患者接受了显微手术切除。所有患者均在多学科肿瘤讨论会上进行了讨论。神经外科治疗的前提是全身疾病稳定,患者的肿瘤内科医生确定预期寿命大于6个月。患者还必须在运动皮质(即中央前回)内有症状性病变。
我们展示了这组患者3个月时的神经功能结果。所有17例患者手术均顺利,无任何严重的围手术期并发症。在3个月的随访中,94.1%的患者症状改善或稳定,5.9%的患者症状恶化。
我们的结果表明,中央前回脑转移瘤的手术可以安全进行,并且可以改善或稳定大多数患者的神经功能。对于出现局灶性神经功能缺损的单发或多发病变患者,中央前回转移瘤的显微手术切除应是一种治疗选择。这可以安全进行,且无需术中皮质定位。